WHO Grade 3 Glioma Recruiting Phase 1 Trials for Pamiparib (DB14769)

Also known as: WHO Grade III Gliomas / Grade III Glioma / WHO Grade III Glioma

IndicationStatusPhase
DBCOND0146359 (WHO Grade 3 Glioma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03749187BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasTreatment